← back to search

Peter Chin

Dartmouth College · US
Area of research
Pathology and Forensic Medicine · Artificial Intelligence
Research interest
Research interests include Multiple Sclerosis Research Studies, Adversarial Robustness in Machine Learning, Topic Modeling, and Lysosomal Storage Disorders Research.
h-index
27
citations
6,644
works
176
NIH funding
primary concept
email

Recent publications

Construction of early warning classification of risk in bladder spasm and its intervention plans guided by the rate adjustment card of continuous bladder irrigation after transurethral resection of the prostate (TURP): development and usability study
Translational Andrology and Urology 2024cited by 4position: middledoi
What Is Learned in Knowledge Graph Embeddings?
Studies in computational intelligence 2022cited by 0position: middledoi
Evaluation of multiple sclerosis disability outcome measures using pooled clinical trial data
Neurology 2019cited by 93position: middledoi
Evaluation of no evidence of progression or active disease (NEPAD) in patients with primary progressive multiple sclerosis in the ORATORIO trial
Annals of Neurology 2018cited by 55position: middledoi
The MSOAC approach to developing performance outcomes to measure and monitor multiple sclerosis disability
Multiple Sclerosis Journal 2017cited by 64position: middledoi
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis
New England Journal of Medicine 2016cited by 1,934position: middledoi
A Fully Integrated Wireless Compressed Sensing Neural Signal Acquisition System for Chronic Recording and Brain Machine Interface
IEEE Transactions on Biomedical Circuits and Systems 2016cited by 146position: middledoi
Impact of a switch to fingolimod on depressive symptoms in patients with relapsing multiple sclerosis: An analysis from the EPOC (Evaluate Patient OutComes) trial
Journal of the Neurological Sciences 2016cited by 33position: middledoi
Efficacy and Safety of Ocrelizumab in Primary Progressive Multiple Sclerosis: Results of the Phase III Double-Blind, Placebo-Controlled ORATORIO Study (S49.001)
Neurology 2016cited by 22position: middledoi
A closed-loop compressive-sensing-based neural recording system
Journal of Neural Engineering 2015cited by 32position: middledoi
Estimating Time to Disease Progression Comparing Transition Models and Survival Methods—An Analysis of Multiple Sclerosis Data
Biometrics 2013cited by 17position: middledoi

Grants

ATD: Collaborative Research: Spectral Interpretations of Essential Subgraphs for Threat Discoveries
NSF2228176$6,6392022–2022PIRePORTER
ATD: Collaborative Research: Spectral Interpretations of Essential Subgraphs for Threat Discoveries
NSF1737897$119,8962017–2022PIRePORTER

Frequent collaborators

Hideki Garren · Prothena (United States)3 papers (2016–2018)Xavier Montalbán · Fundació ACE3 papers (2016–2018)Jerry S. Wolinsky · The University of Texas Health Science Center3 papers (2016–2018)Donna Masterman · ADS Group2 papers (2016–2016)Gavin Giovannoni · Royal London Hospital for Integrated Medicine2 papers (2016–2018)Bernhard Hemmer · Munich Cluster for Systems Neurology2 papers (2016–2016)Shibeshih Belachew · Allgemeine Gewerbeschule Basel2 papers (2016–2018)Ralph Etienne‐Cummings · Johns Hopkins Medicine2 papers (2015–2016)Paulo Fontoura · Roche (Switzerland)2 papers (2016–2016)Kottil Rammohan · University of Miami2 papers (2016–2016)Douglas L. Arnold · Montreal Neurological Institute and Hospital2 papers (2016–2016)Amit Bar‐Or · University of California System2 papers (2016–2016)Trac D. Tran · Johns Hopkins University2 papers (2015–2016) · 2 papers (2015–2016)Timothy H. Lucas · The Ohio State University Wexner Medical Center1 papers (2016–2016)Zheng-Zheng Ma · Soochow University1 papers (2024–2024)Yanhong Ding · Weifang Medical University1 papers (2024–2024) · 1 papers (2018–2018) · 1 papers (2016–2016)Ellen M. Mowry · Johns Hopkins University1 papers (2019–2019)